000 01413 a2200421 4500
005 20250513041852.0
264 0 _c19950608
008 199506s 0 0 eng d
022 _a1043-0342
024 7 _a10.1089/hum.1995.6.2-195
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSobol, R E
245 0 0 _aInjection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study.
_h[electronic resource]
260 _bHuman gene therapy
_cFeb 1995
300 _a195-204 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCell Transplantation
650 0 4 _aClinical Protocols
650 0 4 _aClinical Trials, Phase I as Topic
650 0 4 _aColonic Neoplasms
_xtherapy
650 0 4 _aFibroblasts
650 0 4 _aGene Transfer Techniques
_xadverse effects
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aHumans
650 0 4 _aInformed Consent
650 0 4 _aInterleukin-2
_xgenetics
700 1 _aRoyston, I
700 1 _aFakhrai, H
700 1 _aShawler, D L
700 1 _aCarson, C
700 1 _aDorigo, O
700 1 _aGjerset, R
700 1 _aGold, D P
700 1 _aKoziol, J
700 1 _aMercola, D
773 0 _tHuman gene therapy
_gvol. 6
_gno. 2
_gp. 195-204
856 4 0 _uhttps://doi.org/10.1089/hum.1995.6.2-195
_zAvailable from publisher's website
999 _c7733888
_d7733888